Pharmaceutical Composition Having A Ruthenium Oxalato Compound And Method Of Using The Same
The Present Invention Relates To A Pharmaceutical Composition Comprising One Or More Of The Following Ruthenium Oxalato Compounds I, Ii, Iii And Iv As An Active Ingredient. The Pharmaceutical Composition Can Be Used For The Treatment Of Viral-Infected Patients Or Prophylactic Treatment Of Patients At Risk From Viral Infection.
Patent Number: US7648977B2
Application Number: US2005256175A
Inventor: Che, Chi-Ming | Sun, Raymond Wai-Yin | Wong, Ella Lai-Ming
Priority Date: 24 Oct 2005
Priority Number: US7648977B2
Application Date: 24 Oct 2005
Publication Date: 19 Jan 2010
IPC Current: A61K0031555 | A61K003128
US Class: 514185 | 514184 | 514492
Assignee Applicant: The University of Hong Kong
Title: Pharmaceutical composition having a ruthenium oxalato compound and method of using the same
Usefulness: Pharmaceutical composition having a ruthenium oxalato compound and method of using the same
Summary: For the treatment or prophylaxis of a virus-associated infection such as human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis A virus (HAV), human hepatitis C virus (HCV), severe acute respiratory syndrome associated coronavirus (SARS-CoV), herpes simplex virus, human papillomavirus, human herpesvirus, influenza virus, or simian immunodeficiency virus (SIV), in a patient and in cell based assay (patient and cell are of Animalia kingdom). The cells are Hut/CCR5, GHOST/CXCR4 and PMBC cells (claimed).
Novelty: Composition used for treatment or prophylaxis of virus-associated infection comprises ruthenium oxalato compound
Biomedical
Medical Composition
Hong Kong
